latest news releases from the newsroom
First Security Group, Inc.
First Security Group, Inc. Doubles Fourth Quarter Cash Dividend to $.05 Per Share
CHATTANOOGA, Tenn., Oct. 31, 2006 (PRIMEZONE) -- First Security Group, Inc. (Nasdaq:FSGI), a community bank holding company serving middle and eastern Tennessee and northern Georgia, announced that its board of directors at its regular meeting declared a quarterly cash dividend of $0.05 per share on the Company's common stock. The dividend represents an increase of 100 percent over the $0.025 per share paid quarterly since the Company began to pay a cash dividend in the fourth quarter of 2005. The dividend will be payable on December 18, 2006 to shareholders of record on December 1, 2006.
Seadrill Ltd: Disclosure Regarding Aker Drilling ASA
HAMILTON, Bermuda, Oct. 31, 2006 (PRIMEZONE) -- On October 30, 2006, Seadrill purchased 8,565,800 shares in Aker Drilling ASA at an average price of NOK 34.999. After these transactions Seadrill's shareholding in Aker Drilling ASA totals 9,309,400 shares corresponding to 10.01 percent of total outstanding shares in Aker Drilling ASA.
NDS Group plc
NDS Group Plc Reports First Quarter Results
NEW YORK and LONDON, Oct. 31, 2006 (PRIMEZONE) --NDS Group plc ("NDS" or the "Company") (Nasdaq:NNDS), a majority owned subsidiary of News Corporation, and which supplies open end-to-end digital technology and services to digital pay-television platform operators and content providers, announced today its results for the quarter ended September 30, 2006.
Speedel Begins Phase IIa Trial With Next Generation Renin Inhibitor
BASEL, Switzerland and BRIDGEWATER, N.J., Oct. 31, 2006 (PRIMEZONE) -- Speedel (SWX:SPPN) announces that it has reached another significant milestone in the development of its family of renin inhibitors with the start of a Phase IIa clinical trial with SPP635 for the treatment of hypertension. This compound is the first of a next generation of renin inhibitors following Speedel's lead product SPP100 (aliskiren, Tekturna(1)), which is partnered with Novartis and awaiting marketing approval from the FDA and the EMEA(2). SPP635 is the most advanced compound in the SPP600 series and is one of several new proprietary renin inhibitors invented by Speedel Experimenta, the company's late-stage research unit.
SuperCommunity Bank Conferences
Mid-Atlantic SuperCommunity Bank Conference, November 6th - 7th, 2006
PHILADELPHIA, Oct. 30, 2006 (PRIMEZONE) -- The Mid-Atlantic SuperCommunity Bank Conference will take place in Philadelphia on November 6th and 7th, 2006. The conference will feature 16 community banks presenting to an audience of institutional investors, high net-worth individuals, and analysts from leading investment banks. The conference provides small and mid-cap banks with an opportunity to reach a wide audience of investors specifically interested in this sector of the banking industry.